April 20, 2017
Japanese generic major Sawai Pharmaceutical will acquire privately-held US peer Upsher-Smith Laboratories for US$1.05 billion, the two companies said on April 20. The transaction is expected to close by the end of June. The deal marks Sawai’s first overseas investment...read more